Antiretroviral therapy coverage for PMTCT in Yemen

Yemen: Antiretroviral therapy coverage for PMTCT was 11.0% in 2024. ◆ Volatile

Latest (2024)
11.0%
Change on year
down 15.4%
World rank
83rd
of 84 countries
All-time high
14.0%
in 2022
All-time low
0.0%
in 2000
Years of data
24
2000–2024

Antiretroviral therapy coverage for PMTCT in Yemen, 2000–2024

0510152000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 0 % of pregnant women living with HIV2004: 0 % of pregnant women living with HIV2005: 0 % of pregnant women living with HIV2006: 0 % of pregnant women living with HIV2007: 1 % of pregnant women living with HIV2008: 1 % of pregnant women living with HIV2009: 5 % of pregnant women living with HIV2010: 6 % of pregnant women living with HIV2011: 2 % of pregnant women living with HIV2012: 4 % of pregnant women living with HIV2013: 5 % of pregnant women living with HIV2014: 5 % of pregnant women living with HIV2015: 4 % of pregnant women living with HIV2017: 4 % of pregnant women living with HIV2018: 3 % of pregnant women living with HIV2019: 3 % of pregnant women living with HIV2020: 2 % of pregnant women living with HIV2021: 4 % of pregnant women living with HIV2022: 14 % of pregnant women living with HIV2023: 13 % of pregnant women living with HIV2024: 11 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage for pmtct in Yemen is 11.0%, measured in 2024.

The figure is down 15.4% on the previous year and up 120.0% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Yemen peaked at 14.0% in 2022 and was at its lowest, 0.0%, in 2000.

Yemen ranks 83rd of 84 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Yemen, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Yemen, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 0.0%
2006 0.0%
2007 1.0%
2008 1.0% +0.0%
2009 5.0% +400.0%
2010 6.0% +20.0%
2011 2.0% -66.7%
2012 4.0% +100.0%
2013 5.0% +25.0%
2014 5.0% +0.0%
2015 4.0% -20.0%
2017 4.0% +0.0%
2018 3.0% -25.0%
2019 3.0% +0.0%
2020 2.0% -33.3%
2021 4.0% +100.0%
2022 14.0% +250.0%
2023 13.0% -7.1%
2024 11.0% -15.4%

Yemen compared with similar countries

  • Yemen's 11.0% is below the median for low income countries, which is 73.0%, 15% of the median. (22 countries reporting)
  • Yemen's 11.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 34% of the median. (9 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Yemen changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2009 +400.0% 1.0% 5.0%
2022 +250.0% 4.0% 14.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.7% 0.0% 5.0% 10
2010s 4.0% 2.0% 6.0% 9
2020s 8.8% 2.0% 14.0% 5

Countries ranked near Yemen

  1. 80 Philippines 16.0% compare
  2. 81 Afghanistan 14.0% compare
  3. 81 Pakistan 14.0% compare
  4. 84 Sudan 5.0% compare

See the full ranking of 99 places →

More health data for Yemen

All data for Yemen →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Yemen?
Antiretroviral therapy coverage for pmtct in Yemen was 11.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Yemen?
The highest recorded value was 14.0% in 2022.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Yemen?
The lowest recorded value was 0.0% in 2000.
How does Yemen rank for antiretroviral therapy coverage for pmtct?
Yemen ranks 83rd out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Yemen?
Over the last ten years it is up 120.0%. The long-run trend across the full record is volatile.
Where does this Yemen data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Yemen. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/yemen-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/yemen-rep/">Antiretroviral therapy coverage for PMTCT in Yemen</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).